Retinalgenix Technologies Inc. - 8-K

Filed Mar 26, 2026. See issuer overview · financials · original on SEC.gov ↗

Accession

0001493152-26-012957

5.02

Item 5.02 - Departure/Election of Directors or Certain Officers

59 words

Item
5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.

On
March 22, 2026, Michael Cory Zwerling, the Chief Financial Officer of RetinalGenix Technologies Inc. (the “Company”), notified
the Company of his decision to resign, effective immediately, from his position as the Company’s Chief Financial Officer.

- 2 -